Literature DB >> 23431072

Type of PKD1 mutation influences renal outcome in ADPKD.

Emilie Cornec-Le Gall1, Marie-Pierre Audrézet, Jian-Min Chen, Maryvonne Hourmant, Marie-Pascale Morin, Régine Perrichot, Christophe Charasse, Bassem Whebe, Eric Renaudineau, Philippe Jousset, Marie-Paule Guillodo, Anne Grall-Jezequel, Philippe Saliou, Claude Férec, Yannick Le Meur.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, as well as phenotypic variability. The genotype-phenotype relationship in ADPKD is not completely understood. Here, we studied 741 patients with ADPKD from 519 pedigrees in the Genkyst cohort and confirmed that renal survival associated with PKD2 mutations was approximately 20 years longer than that associated with PKD1 mutations. The median age at onset of ESRD was 58 years for PKD1 carriers and 79 years for PKD2 carriers. Regarding the allelic effect on phenotype, in contrast to previous studies, we found that the type of PKD1 mutation, but not its position, correlated strongly with renal survival. The median age at onset of ESRD was 55 years for carriers of a truncating mutation and 67 years for carriers of a nontruncating mutation. This observation allows the integration of genic and allelic effects into a single scheme, which may have prognostic value.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23431072      PMCID: PMC3665389          DOI: 10.1681/ASN.2012070650

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.

Authors:  Sandro Rossetti; Katharina Hopp; Robert A Sikkink; Jamie L Sundsbak; Yean Kit Lee; Vickie Kubly; Bruce W Eckloff; Christopher J Ward; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 3.  Determinants of renal disease variability in ADPKD.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

4.  Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.

Authors:  Carsten Bergmann; Jennifer von Bothmer; Nadina Ortiz Brüchle; Andreas Venghaus; Valeska Frank; Henry Fehrenbach; Tobias Hampel; Lars Pape; Annegret Buske; Jon Jonsson; Nanette Sarioglu; Antónia Santos; Jose Carlos Ferreira; Jan U Becker; Reinhold Cremer; Julia Hoefele; Marcus R Benz; Lutz T Weber; Reinhard Buettner; Klaus Zerres
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

5.  A missense mutation in PKD1 attenuates the severity of renal disease.

Authors:  York Pei; Zheng Lan; Kairong Wang; Miguel Garcia-Gonzalez; Ning He; Elizabeth Dicks; Patrick Parfrey; Gregory Germino; Terry Watnick
Journal:  Kidney Int       Date:  2011-10-26       Impact factor: 10.612

6.  Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.

Authors:  Bjarne Orskov; Karl B Christensen; Bo Feldt-Rasmussen; Svend Strandgaard
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

7.  Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

Authors:  Mihailo Vujic; Christina M Heyer; Elisabet Ars; Katharina Hopp; Arseni Markoff; Charlotte Orndal; Bengt Rudenhed; Samih H Nasr; Vicente E Torres; Roser Torra; Nadja Bogdanova; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

8.  Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.

Authors:  Sean V Tavtigian; Graham B Byrnes; David E Goldgar; Alun Thomas
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  Unified criteria for ultrasonographic diagnosis of ADPKD.

Authors:  York Pei; James Obaji; Annie Dupuis; Andrew D Paterson; Riccardo Magistroni; Elizabeth Dicks; Patrick Parfrey; Benvon Cramer; Eliecer Coto; Roser Torra; Jose L San Millan; Robert Gibson; Martijn Breuning; Dorien Peters; David Ravine
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

10.  Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.

Authors:  Sandro Rossetti; Vickie J Kubly; Mark B Consugar; Katharina Hopp; Sushmita Roy; Sharon W Horsley; Dominique Chauveau; Lesley Rees; T Martin Barratt; William G van't Hoff; Patrick Niaudet; W Patrick Niaudet; Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-01-21       Impact factor: 10.612

View more
  177 in total

1.  Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Authors:  Yiqiang Cai; Sorin V Fedeles; Ke Dong; Georgia Anyatonwu; Tamehito Onoe; Michihiro Mitobe; Jian-Dong Gao; Dayne Okuhara; Xin Tian; Anna-Rachel Gallagher; Zhangui Tang; Xiaoli Xie; Maria D Lalioti; Ann-Hwee Lee; Barbara E Ehrlich; Stefan Somlo
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Can ultrasound kidney length qualify as an early predictor of progression to renal insufficiency in autosomal dominant polycystic kidney disease?

Authors:  Emilie Cornec-Le Gall; Yannick Le Meur
Journal:  Kidney Int       Date:  2015-12       Impact factor: 10.612

3.  Slowing Polycystic Kidney Disease by Fasting.

Authors:  Alessandra Boletta
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

4.  The Polycystin-1, Lipoxygenase, and α-Toxin Domain Regulates Polycystin-1 Trafficking.

Authors:  Yaoxian Xu; Andrew J Streets; Andrea M Hounslow; Uyen Tran; Frederic Jean-Alphonse; Andrew J Needham; Jean-Pierre Vilardaga; Oliver Wessely; Michael P Williamson; Albert C M Ong
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 5.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 6.  Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Hannah A Blair; Gillian M Keating
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

7.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

8.  Biallelic Mutations in DNAJB11 are Associated with Prenatal Polycystic Kidney Disease in a Turkish Family.

Authors:  Esra Arslan Ateş; Ayberk Turkyilmaz; Kenan Delil; Ceren Alavanda; Mehmet Ali Söylemez; Bilgen Bilge Geçkinli; Pinar Ata; Ahmet Arman
Journal:  Mol Syndromol       Date:  2021-04-01

Review 9.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

10.  Polycystic kidney disease: Kidney volume--a crystal ball for ADPKD prognosis?

Authors:  Emilie Cornec-Le Gall; Yannick Le Meur
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.